MedCity News

Amazon Taps Expressable for Health Benefits Connector

Roche Gains Rights to Hanmi Obesity Drug That Reduces Fat, Preserves Muscle

Hanmi Pharmaceutical’s drug is designed to activate a receptor in skeletal muscle to both increase muscle mass and reduce fat. This engineered peptide gives Roche a clinical-stage asset that addresses a different target than the other obesity drugs in its pipeline.

By Frank Vinluan

A Partnership-driven Approach to Waste and Abuse Prevention

Discover how payers can shift from costly post-payment recovery to intentional prevention through data-driven oversight, accountability, and partnership.

By Cotiviti

MedCity Influencers

Sad woman crying watercolor painting texture on white background, mental health, illness ,brain development ,medical treatment concept

Why Psychiatry Can’t Ignore Metabolic Health Anymore

Metabolic psychiatry has moved past being a fringe theory. It is a practical, evidence-based necessity for a field that has been stagnant for too long.

By Scott Fears

Latest Video

Latest News

Artificial Intelligence, Health Tech, Providers

Male doctor working on laptop in exam room

Ambient Scribes Improve Clinician Retention, Cleveland Clinic Research Shows

A new paper shows Cleveland Clinic's AI scribe rollout is paying dividends in clinician satisfaction and retention. These are key metrics for hospitals to track, given they spend millions on recruitment and retention efforts amid an ongoing workforce crisis.

By Katie Adams

BioPharma, Startups

Abcuro Adds $66M to Try Again in Rare Inflammatory Disorder With No Approved Drugs

Abcuro will apply the capital to a study that could support a biologics license application in inclusion body myositis, a rare inflammatory disorder that leads to worsening muscle weakness. A Phase 2/3 study failed earlier this year, but Abcuro saw positive trends in patients with less severe disease.

By Frank Vinluan

Health Tech, Payers

Cityblock to Acquire Homeward Health, Secures $116M Series E

Cityblock Health plans to acquire rural healthcare provider Homeward Health and has raised $116 million to expand its value-based care model to rural and Medicare Advantage populations.

By Marissa Plescia

MedCity Influencers

Woman embracing daughter while looking at female nurse holding clipboard - impact of Medicaid cuts.

How to Prepare Your Hospital Before H.R. 1 Hits in 2027

But the deadline that most people are not tracking, and the most worrisome, is October 1, 2026. It’s the day federal Medicaid funding ends for the country’s most vulnerable populations, including refugees, asylees, and humanitarian parolees.

By Scott Schrader

Artificial Intelligence, Health Tech

This Week In Epic News: FTC Probe, AI Agents & More

Epic faced an FTC antitrust probe this week, but that didn't stop the EHR giant from unveiling a wave of new AI tools at its annual conference.

By Katie Adams

BioPharma, Pharma

Ambros Therapeutics’ Path for Pain Drug Goes Through Reverse Merger With Werewolf

Along with Ambros Therapeutics’ merger with Werewolf Therapeutics, the combined company will raise $150 million in a private placement. Ambros is in Phase 3 testing with a drug developed for treating a type of pain that does not respond to currently available medicines, including opioids.

By Frank Vinluan

MedCity Influencers

The Pulse of Innovation: How 3D Models Can Prepare Surgeons for the Operating Room

Today, 3D modeling and printing technology can make a dramatic impact — even shortening some operations by 30-90 minutes. Looking ahead, that reduction will only grow as the technology is further integrated and becomes more advanced.

By Justin Ryan

Where Will AI Deployment Benefit Payers the Most?

We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.

By MedCity News

MedCity Influencers

Wooden mannequin holding a US $100 dollar bill on a defocused stethoscope background.

Modernizing Payment Integrity in an Era of Systemic Fraud

Gaps in reimbursement oversight and recovery will only widen, unless plans modernize how they detect, investigate, and recoup improper payments.

By Christian Bass

Payers

SCAN, Costco Launch Medicare Partnership

SCAN Health Plan and Costco are partnering to provide a suite of insurance products for seniors.

By Marissa Plescia

BioPharma, Pharma

Ultragenyx Gene Therapy Becomes First FDA-Approved Treatment for Ultra-Rare Disease

Ultragenyx Pharmaceutical’s Genglycos received accelerated FDA approval for glycogen storage disease type Ia, an inherited enzyme deficiency. It’s also the first approved gene therapy for Ultragenyx, which specializes in rare disease treatments.

By Frank Vinluan

Opinion

The Imperative of Distinguishing Medical-Grade Devices from Wellness Tech

Why the flood of consumer wellness devices demands clear boundaries between lifestyle improvement and clinical diagnostics

By Dave Albert

MedCity Influencers

Digital balancing scale justice, fairness in modern technology environment. Holographic scales balance on illuminated datum background of ai circuitry. Innovation concept in abstract futuristic

AI in Pharmacovigilance: Why Governance Will Define Success

As adoption accelerates, organizations must ensure that the use of AI strengthens and not weakens accountability and patient safety.

By Anuradha (Annie) Prabhakar

Devices & Diagnostics, Health Tech

Happy Health Snags $75M to Support Home-Based Care

Happy Health's $75 million round was from ARCH Venture Partners and OpenLoop.

By Marissa Plescia

BioPharma, Pharma

Merck, Moderna Personalized mRNA Cancer Therapy Achieves a First for Melanoma

Merck and Moderna said intismeran autogene, an mRNA cancer vaccine that prompts an immune response to proteins expressed by a patient’s tumors, met the main goal of a pivotal test in melanoma. It’s the most advanced trial in a 50/50 partnership evaluating the personalized cancer treatment in a wide range of tumor types.

By Frank Vinluan

Opinion

Why Bone Health Is Preventive Healthcare’s Next Big Category

The next healthcare revolution isn't about treating osteoporosis, it's about preserving mobility and healthspan.

By Laura Yecies